trial · primary record
Rifapentine
Tuberculosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 144 |
| Primary completion | 2028-11-15 |
| Primary endpoint | Plasma concentration of Rifapentine (RPT) at specified time points among children with and without HIV |
| Registry ID | NCT07124559 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:19.236Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07124559
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Rifapentine · approval
- Rifapentine · compound